In collaboration with CPI’s Medicines Manufacturing Innovation Centre, PharmaTech Integrates brings together experts in disruptive advanced medicines manufacturing and digital technologies. This event engages the broadest possible network of pharmaceutical innovators, regulators, supply chain partners, equipment and technology providers, academia, and industry associations.
In 2025, the pharma industry is facing unprecedented change, with the emergence of increasingly complex, but highly effective therapeutic modalities driven by ever more sophisticated understanding of genomics and the fundamental causes of disease. This is coupled with the disruptive force of the information age, promise of AI and manifold other technology advances that hold immense promise, but can be challenging to deploy in the ‘real world’.
PharmaTech Integrates 2025 will explore these themes and discuss how these trends can be brought together to deliver the industry of the future.
AI has evolved from a promising innovation to a transformational force in pharmaceutical R&D, manufacturing and supply chain optimisation. But as the industry moves beyond early adoption, the big questions remain—how effective is AI in practice, and where are the real opportunities for impact?
How can pharmaceutical businesses ensure they are integrating necessary digital and data infrastructure effectively? More importantly, how does this translate into tangible benefits for quality, compliance and operational efficiency, whilst remaining sustainable?
As the industry faces mounting pressure to boost efficiency, minimise waste and strengthen supply chain resilience, process intensification is emerging as a game-changer for pharma manufacturing. This panel will explore how advanced process technologies, from continuous manufacturing to micro-factories, are reshaping production. But what are the barriers to widespread adoption, and how can the industry navigate the challenges ahead?
Some advanced therapies are produced with highly labour-intensive but repetitive processes. Automated manufacturing is promising to deliver dramatic productivity and reproducibility improvements, along with significant enhancements to return of capital, but will it deliver? What role can robotics play in the production of pharmaceuticals of the future?
The concept of truly personalised therapies is often talked about but seldom delivered. How can emergent pharma technologies support the delivery of truly tailored therapies, to bring outstanding patient outcomes?
For 2025, we will be running sessions at CPI’s Medicines Manufacturing Innovation Centre (MMIC).
The Medicines Manufacturing Innovation Centre was created by CPI to develop, prove and commercialise disruptive technologies for the pharmaceutical industry. Click here to view map and driving directions to the Medicines Manufacturing Innovation Centre.
Click here to see full Public Transport and Parking Details.
Advanced Manufacturing Innovation District Scotland (AMIDS), Netherton Square, Paisley, Glasgow, PA3 2EF